Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LSM14B | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | ZMAT4 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | UHRF1 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | CH507-396I9.3 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
mRNA | ZNF181 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | APH1A | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
mRNA | SCAMP3 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
mRNA | RFT1 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
mRNA | RP11-1212A22.4 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
mRNA | LRRC75A | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |